Patent Assignment
Reel/Frame 059059/0193
Assignment of Assignor's Interest
Recorded: 2022-02-21
Pages: 3
Assignor
ST. CLAIR BROWN, ADRIAN
Executed: 2010-01-15
Assignee
PHARMORPHIX
250 SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0WE, UNITED KINGDOM
Covered Properties
(2)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
Application:
17/371,372 →
Publication:
US 2022/0259151
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application:
17/505,275 →
Publication:
US 2022/0033357
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 21, 2022
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 059058/0975 →
Assignment of Assignor's Interest
Feb 21, 2022
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 059059/0018 →
Assignment of Assignor's Interest
Feb 21, 2022
From: BRISTOL-MYERS SQUIBB COMPANY
To: EXELIXIS, INC.
Reel/Frame 059059/0145 →
Assignment of Assignor's Interest
Feb 21, 2022
From: PHARMORPHIX
To: EXELIXIS, INC.
Reel/Frame 059059/0173 →